Skip to main content
Clinical Trials/NCT02766751
NCT02766751
Completed
Not Applicable

Treating Comorbid Pain and Depression in HIV+ Individuals

Butler Hospital4 sites in 1 country187 target enrollmentNovember 15, 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
HIV
Sponsor
Butler Hospital
Enrollment
187
Locations
4
Primary Endpoint
pain interference
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study is designed to look at two different programs that may help people who are HIV+ and have pain and depression. The investigators are trying to understand how to help people learn to live better lives even with these chronic illnesses.

Detailed Description

The primary aim of this RCT is to evaluate the HIVPass intervention. HIV+ participants (n=236) with chronic pain and depression will be recruited at primary care HIV Clinics through posted advertisements in the waiting rooms of the PCP offices and by physician referral. After an initial phone study screen, research staff will meet with interested individuals in their PCP offices for informed consent, baseline interview and randomization into one of two study groups (Health Education or HIVPass Counseling). Seven intervention sessions (HE or HIVPASS) will occur during the first 3 months of study participation. For all participants, the first session is a collaborative in-person joint session with the participant, his/her PCP and the study BHS. Session 2 is conducted immediately after this collaborative session, and is also in-person. Sessions 3-7 are conducted by phone. Follow-up assessment interviews will be at months 1, 2, 3 (post-intervention), 4, 6, 9 and 12.

Registry
clinicaltrials.gov
Start Date
November 15, 2016
End Date
May 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Michael Stein, MD

Principal Investigator

Butler Hospital

Eligibility Criteria

Inclusion Criteria

  • Chronic Pain (pain duration for at least six months with a mean score of greater than 3.5 on the BPI Pain Interference Scale)
  • Pain severity \> or equal to 4 on a Numeric Rating Scale indicating "average pain in the last week"
  • At least one trial of PCP-recommended medication (i.e. acetaminophen, NSAIDS, muscle relaxants) judged through interviews with patients and PCPs
  • Quick Inventory of Depression Symptoms (QIDS) score of ≥ 9 (depression severity)
  • Stable dose of an antidepressant, if using, for the previous 1 months
  • Age \> or equal to 18
  • Planning to live in the area for the next 6 months
  • Access to a telephone that is typically working.

Exclusion Criteria

  • In psychotherapy or a multidisciplinary pain management program
  • Planned surgery in the next 6 months
  • Pain thought due to cancer
  • Current mania
  • Past year chronic psychotic condition
  • Excessive substance use (Use of cocaine, heroin, or non-prescribe opioids 15 days per month or more; binge alcohol use 4 days per month or more)
  • Suicidality requiring immediate attention
  • Pregnancy or planned pregnancy in the next 6 months

Outcomes

Primary Outcomes

pain interference

Time Frame: 3 months

Brief pain inventory, interference scale

Secondary Outcomes

  • depression(3 months; 12 months)
  • activity level(3 months; 12 months)
  • anxiety(3 months; 12 months)
  • viral load(3 months, 12 months)
  • perception of global improvement(3 months, 12 months)
  • health related quality of life(3 months, 12 onths)
  • ART adherence(3 months, 12 months)
  • pain interference(12 months)

Study Sites (4)

Loading locations...

Similar Trials